BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 238675)

  • 1. Immunodeficiency in the Wiskott-Aldrich syndrome.
    Blaese RM; Strober W; Waldmann TA
    Birth Defects Orig Artic Ser; 1975; 11(1):250-4. PubMed ID: 238675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome.
    Oppenheim JJ; Blaese RM; Waldmann TA
    J Immunol; 1970 Apr; 104(4):835-44. PubMed ID: 4986478
    [No Abstract]   [Full Text] [Related]  

  • 3. Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.
    Zabay JM; Fontán G; Campos A; García-Rodriguez MC; Pascual-Salcedo D; Bootello A; de la Concha EG
    Clin Exp Immunol; 1984 Apr; 56(1):23-8. PubMed ID: 6609033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).
    Sherwood G; Blaese RM
    Clin Exp Immunol; 1973 Apr; 13(4):515-20. PubMed ID: 4736825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte transformation in vitro in patients with immunodeficiency diseases: use in diagnosis, histocompatibility testing and monitoring treatment.
    Dupont B; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):477-85. PubMed ID: 50099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-macrophage interaction in antigen induced in vitro lymphocyte transformation in patients with the Wiskott-Aldrich syndrome and other diseases with anergy.
    Blaese RM; Oppenheim JJ; Seeger RC; Waldmann TA
    Cell Immunol; 1972 Jul; 4(3):228-42. PubMed ID: 4402568
    [No Abstract]   [Full Text] [Related]  

  • 8. Dichotomy of antibody response to group A streptococcal antigens in Wiskott-Aldrich syndrome.
    Ayoub EM; Dudding BA; Cooper MD
    J Lab Clin Med; 1968 Dec; 72(6):971-9. PubMed ID: 5723120
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-capsular polysaccharide antibody deficiency states.
    Rijkers GT; Sanders LA; Zegers BJ
    Immunodeficiency; 1993; 5(1):1-21. PubMed ID: 8167745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions in immunodeficiency.
    Soothill JF
    Birth Defects Orig Artic Ser; 1975; 11(1):50-2. PubMed ID: 1096992
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity.
    Valentine FT; Lawrence HS
    Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
    [No Abstract]   [Full Text] [Related]  

  • 12. Umbilical cord blood transplantation in Wiskott Aldrich syndrome.
    Knutsen AP; Steffen M; Wassmer K; Wall DA
    J Pediatr; 2003 May; 142(5):519-23. PubMed ID: 12756384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo immune response to specific antigens in canine marrow graft recipients.
    Abb J; Kolb HJ; Rodt HV; Grosse-Wilde H; Rieder I; Thierfelder S
    Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):152-61. PubMed ID: 71795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
    Millikan LE
    Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular and humoral defense. Significance in hematology and immunopathology].
    Tilz GP
    Med Klin; 1972 Mar; 67(10):341-5. PubMed ID: 5063220
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis.
    Ammann AJ; Addiego J
    Lancet; 1978 Oct; 2(8093):789-90. PubMed ID: 80713
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of Wiskott-Aldrich syndrome with specific immunological deficiencies].
    De Filippo P; Tomasi L; Cerbone C
    Pediatria (Napoli); 1976 Mar; 84(1):110-9. PubMed ID: 1021786
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of the transfer factor].
    Mutz I; Humphrey GB
    Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
    [No Abstract]   [Full Text] [Related]  

  • 19. A cellular basis for auto-immunity.
    Playfair JH
    Essays Fundam Immunol; 1973; 0(1):44-56. PubMed ID: 4137497
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.